Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
6.5%
% of HART's 77 holdings also in XPH
12.2%
% of XPH's 41 holdings also in HART
Overlap by Weight
Sector Drift (HART minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.0% | 4.2% | 4.2% |
|
ELI LILLY & CO | 4.7% | 4.0% | 4.0% |
|
JOHNSON & JOHNSON | 4.5% | 3.8% | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 3.7% | 3.7% |
|
PFIZER INC | 4.2% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to XPH
 |
NOVO NORDISK A/S-B | 6.1% |
|
APPLE INC | 5.5% |
|
ALPHABET INC. CLASS A | 5.4% |
 |
ASTRAZENECA PLC | 5.2% |
 |
NESTLE SA-REG | 5.1% |
|
NOVARTIS AG | 4.9% |
|
ABBOTT LABORATORIES | 4.7% |
|
UNITEDHEALTH GROUP INC | 4.6% |
|
NIKE INC -CL B | 1.5% |
|
ANTHEM INC | 1.1% |
HART Underweight Relative to XPH
|
CATALENT INC | -6.6% |
|
REVANCE THERAPEUTICS INC | -6.0% |
|
REATA PHARMACEUTICALS, INC. CLASS A | -5.5% |
 |
PERRIGO CO | -4.8% |
|
ZOETIS INC | -4.7% |
|
JAZZ PHARMACEUTICALS PLC | -3.9% |
|
VIATRIS, INC. | -3.8% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
|
ORGANON & CO. | -3.5% |